This study presents valuable findings implicating nuclear export in the regulation of protein condensate behaviour and TDP-43 phase behaviour, suggesting a link to pathogenic aggregation in ALS/FTD.
The company combines a hyper-efficient automated platform with massive account growth to justify the stock's premium valuation.